The NOS1 variant rs6490121 is associated with variation in prefrontal function and grey matter density in healthy individuals
暂无分享,去创建一个
Thomas Frodl | Ian H. Robertson | Fiona N. Newell | Sinead Kelly | John P. O'Doherty | Arun L. W. Bokde | Hugh Garavan | Michael Gill | Derek W. Morris | Aiden P. Corvin | Emma J. Rose | Gary Donohoe | Sarah Jacobson | Ciara Fahey | Ciara Greene | Jane McGrath | M. Gill | F. Newell | I. Robertson | A. Corvin | D. Morris | H. Garavan | S. Kelly | Arun L. W. Bokde | T. Frodl | C. Fahey | E. Rose | G. Donohoe | C. Greene | Sarah Jacobson | J. McGrath | J. O’Doherty
[1] Ann-Christine Ehlis,et al. A functional promoter polymorphism of neuronal nitric oxide synthase moderates prefrontal functioning in schizophrenia. , 2011, The international journal of neuropsychopharmacology.
[2] Lin He,et al. Evidence for association between the 5' flank of the NOS1 gene and schizophrenia in the Chinese population. , 2008, The international journal of neuropsychopharmacology.
[3] Marika Paaver,et al. A functional NOS1 promoter polymorphism interacts with adverse environment on functional and dysfunctional impulsivity , 2011, Psychopharmacology.
[4] John Stewart,et al. A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. , 2002, The American journal of psychiatry.
[5] C. Chiueh,et al. Neurobiology of NO· and ·OH: Basic Research and Clinical Relevance , 1994, Annals of the New York Academy of Sciences.
[6] C. Spencer,et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up , 2008, Nature Genetics.
[7] D Saur,et al. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function , 2006, Molecular Psychiatry.
[8] Mario Engelmann,et al. Impaired cognitive performance in neuronal nitric oxide synthase knockout mice is associated with hippocampal protein derangements. , 2004, Nitric oxide : biology and chemistry.
[9] J. Binder,et al. A Parametric Manipulation of Factors Affecting Task-induced Deactivation in Functional Neuroimaging , 2003, Journal of Cognitive Neuroscience.
[10] N. Toda,et al. Cerebral blood flow regulation by nitric oxide in neurological disorders. , 2009, Canadian journal of physiology and pharmacology.
[11] A. Gürel,et al. Nitric oxide as a physiopathological factor in neuropsychiatric disorders. , 2004, In vivo.
[12] Tim Hahn,et al. NOS1 ex1f‐VNTR polymorphism affects prefrontal oxygenation during response inhibition tasks , 2012, Human brain mapping.
[13] Nicolas Singewald,et al. Nitric oxide modulates the release of serotonin in the rat hypothalamus , 1999, Brain Research.
[14] R. Huganir,et al. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. , 2005, American journal of human genetics.
[15] T. Paus,et al. Functional coactivation map of the human brain. , 2008, Cerebral cortex.
[16] Danielle S Bassett,et al. Cognitive fitness of cost-efficient brain functional networks , 2009, Proceedings of the National Academy of Sciences.
[17] Jörgen A. Engel,et al. Habituation of acoustic startle is disrupted by psychotomimetic drugs: differential dependence on dopaminergic and nitric oxide modulatory mechanisms , 2004, Psychopharmacology.
[18] J. Engel,et al. The neuronal selective nitric oxide synthase inhibitor, Nomega-propyl-L-arginine, blocks the effects of phencyclidine on prepulse inhibition and locomotor activity in mice. , 2004, European journal of pharmacology.
[19] Ian J. Deary,et al. Association of Existing and New Candidate Genes for Anxiety, Depression and Personality Traits in Older People , 2010, Behavior genetics.
[20] G. Wogan,et al. Nitric oxide as a modulator of apoptosis. , 2005, Cancer letters.
[21] C. Chiueh,et al. Neuroprotective Properties of Nitric Oxide , 1999, Annals of the New York Academy of Sciences.
[22] Bernhard Bogerts,et al. The many faces of nitric oxide in schizophrenia. A review , 2005, Schizophrenia Research.
[23] John G. Csernansky,et al. Neurodegeneration in Schizophrenia: Evidence from In Vivo Neuroimaging Studies , 2007, TheScientificWorldJournal.
[24] Karl J. Friston,et al. Voxel-Based Morphometry—The Methods , 2000, NeuroImage.
[25] Shih-Jen Tsai,et al. Association analysis for the CA repeat polymorphism of the neuronal nitric oxide synthase (NOS1) gene and schizophrenia , 2003, Schizophrenia Research.
[26] G L Shulman,et al. INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .
[27] Paul J. Laurienti,et al. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.
[28] Pall I. Olason,et al. Common variants conferring risk of schizophrenia , 2009, Nature.
[29] G. Shulman,et al. Medial prefrontal cortex and self-referential mental activity: Relation to a default mode of brain function , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] Joseph H Callicott,et al. Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls. , 2010, Archives of general psychiatry.
[31] Guy C. Brown,et al. Nitric oxide and neuronal death. , 2010, Nitric oxide : biology and chemistry.
[32] John Ashburner,et al. A fast diffeomorphic image registration algorithm , 2007, NeuroImage.
[33] D. Lorrain,et al. Nitric oxide increases dopamine and serotonin release in the medial preoptic area , 1993, Neuroreport.
[34] Jörgen A. Engel,et al. The nitric oxide synthase inhibitor, L-NAME, blocks phencyclidine-induced disruption of prepulse inhibition in mice , 2001, Psychopharmacology.
[35] D. Schacter,et al. The Brain's Default Network , 2008, Annals of the New York Academy of Sciences.
[36] T. Shinkai,et al. Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia , 2002, Molecular Psychiatry.
[37] D. Jackson,et al. Nitric oxide synthase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat , 1997, Psychopharmacology.
[38] Ann-Christine Ehlis,et al. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. , 2009, Archives of general psychiatry.
[39] Jörgen A. Engel,et al. The nitric oxide synthase inhibitor. L-NAME, blocks certain phencyclidine-induced but not amphetamine-induced effects on behaviour and brain biochemistry in the rat , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[40] D. Bredt,et al. Synaptic signaling by nitric oxide , 1997, Current Opinion in Neurobiology.
[41] R. Turner,et al. Does Hypercapnia-Induced Cerebral Vasodilation Modulate the Hemodynamic Response to Neural Activation? , 2001, NeuroImage.
[42] Kim Fejgin,et al. The amino acid l-lysine blocks the disruptive effect of phencyclidine on prepulse inhibition in mice , 2007, Psychopharmacology.
[43] R W Cox,et al. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. , 1996, Computers and biomedical research, an international journal.
[44] Trevor Archer,et al. Effects of phencyclidine on spatial learning and memory: Nitric oxide-dependent mechanisms , 2006, Behavioural Brain Research.
[45] Maurizio Corbetta,et al. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[46] Mario Engelmann,et al. Neuronal nitric oxide synthase knock-out mice show impaired cognitive performance. , 2004, Nitric oxide : biology and chemistry.
[47] Russell J. Andrews,et al. Neuroprotective agents : seventh international conference , 1997 .
[48] Hidenao Fukuyama,et al. Brain volume and dysexecutive behavior in schizophrenia , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[49] E. Oldfield,et al. Effects of Nitric Oxide on Reactive Oxygen Species Production and Infarction Size after Brain Reperfusion Injury , 2001, Neurosurgery.
[50] Michael Gill,et al. Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects. , 2009, Archives of general psychiatry.
[51] K. Kuriyama,et al. Nitric oxide-evoked [3H] gamma-aminobutyric acid release is mediated by two distinct release mechanisms. , 1996, Brain research. Molecular brain research.
[52] M. Bullock,et al. The Significance of Nitric Oxide Production in the Brain After Injury , 2002, Annals of the New York Academy of Sciences.
[53] Alan C. Evans,et al. Detecting changes in nonisotropic images , 1999, Human brain mapping.
[54] D. Butterfield,et al. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity , 2007, Nature Reviews Neuroscience.
[55] Jörgen A. Engel,et al. Effects of phencyclidine on acoustic startle and prepulse inhibition in neuronal nitric oxide synthase deficient mice , 2005, European Neuropsychopharmacology.
[56] N. Toda,et al. Control of systemic and pulmonary blood pressure by nitric oxide formed through neuronal nitric oxide synthase , 2009, Journal of hypertension.
[58] Ernesto Fedele,et al. The NOS/sGC pathway in the rat central nervous system: a microdialysis overview , 2004, Neurochemistry International.
[59] S. Snyder,et al. Novel neural modulators. , 2003, Annual review of neuroscience.
[60] J. Garthwaite,et al. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain , 1988, Nature.
[61] J. Callicott,et al. Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. , 2007, Cerebral cortex.
[62] Thomas Dresler,et al. NOS1 ex1f-VNTR polymorphism influences prefrontal brain oxygenation during a working memory task , 2011, NeuroImage.
[63] John J. Foxe,et al. A NOS1 variant implicated in cognitive performance influences evoked neural responses during a high density EEG study of early visual perception , 2012, Human brain mapping.
[64] P. Marsden,et al. Structural organization of the human neuronal nitric oxide synthase gene (NOS1). , 1994, The Journal of biological chemistry.
[65] Thomas E. Nichols,et al. Nonstationary cluster-size inference with random field and permutation methods , 2004, NeuroImage.
[66] D. Joel,et al. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum , 2000, Neuroscience.
[67] K. Johnson,et al. Nitric oxide induces neurotransmitter release from hippocampal slices. , 1992, European journal of pharmacology.
[68] S. Siris,et al. Implications of normal brain development for the pathogenesis of schizophrenia. , 1988, Archives of general psychiatry.
[69] Jakob Korf,et al. NEUROBIOLOGY OF NO- AND -OH , 1994 .
[70] Federica Buonocore,et al. Effects of cis-regulatory variation differ across regions of the adult human brain. , 2010, Human molecular genetics.